S
Sara Schroter
Researcher at BMJ Group
Publications - 90
Citations - 5766
Sara Schroter is an academic researcher from BMJ Group. The author has contributed to research in topics: Randomized controlled trial & Medicine. The author has an hindex of 28, co-authored 82 publications receiving 4771 citations. Previous affiliations of Sara Schroter include University of London.
Papers
More filters
Journal ArticleDOI
Prognosis Research Strategy (PROGRESS) 3: prognostic model research.
Ewout W. Steyerberg,Karel G.M. Moons,Daniëlle A W M van der Windt,Jill A. Hayden,Pablo Perel,Sara Schroter,Richard D Riley,Harry Hemingway,Douglas G. Altman +8 more
TL;DR: How prognostic models are developed and validated are reviewed and assessed for their impact on practice and patient outcomes are addressed, illustrating these ideas with examples.
Journal ArticleDOI
Prognosis Research Strategy (PROGRESS) 2: Prognostic Factor Research
Richard D Riley,Jill A. Hayden,Ewout W. Steyerberg,Karel G.M. Moons,Keith R. Abrams,Panayiotis A. Kyzas,Núria Malats,Andrew Briggs,Sara Schroter,Douglas G. Altman,Harry Hemingway +10 more
TL;DR: The role of prognostic factors in current clinical practice, randomised trials, and developing new interventions are discussed, and why and how prognostic factor research should be improved are explained.
Journal ArticleDOI
Prognosis research strategy (PROGRESS) 1: A framework for researching clinical outcomes
Harry Hemingway,Peter Croft,Pablo Perel,Jill A. Hayden,Keith R. Abrams,Adam Timmis,Andrew Briggs,Ruzan Udumyan,Karel G.M. Moons,Ewout W. Steyerberg,Ian Roberts,Sara Schroter,Douglas G. Altman,Richard D Riley +13 more
TL;DR: A framework of four interrelated themes in prognosis research is introduced, describing the importance of the first of these themes (understanding future outcomes in relation to current diagnostic and treatment practices), and recommendations for the field of prognosisResearch are introduced.
Journal ArticleDOI
Prognosis research strategy (PROGRESS) 4: Stratified medicine research
Aroon D. Hingorani,Daniëlle A W M van der Windt,Richard D Riley,Keith R. Abrams,Karel G.M. Moons,Ewout W. Steyerberg,Sara Schroter,Willi Sauerbrei,Douglas G. Altman,Harry Hemingway +9 more
TL;DR: Why prognosis research should form a cornerstone of stratified medicine, especially in regard to the identification of factors that predict individual treatment response, is discussed.
Journal ArticleDOI
Evaluation of outcomes in chronic venous disorders of the leg: Development of a scientifically rigorous, patient-reported measure of symptoms and quality of life☆
TL;DR: The VEINES-QOL/Sym is the only fully validated measure of quality of life and symptoms that is appropriate for use across the full spectrum of CVDL-related conditions and provides a rigorous tool for improving the evaluation of outcomes in clinical trials, epidemiologic studies, and audit.